3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neurofibromatosis 1
2
Pain
1
Noonan Syndrome
1
Neurotoxicity Syndromes
1
Cognition Disorders
1
Interventions
osimertinib
2
sotorasib
1
pembrolizumab
1
nazartinib
1
cobimetinib
1
Waiting Lists
1
Lovastatin
1
Lamotrigine
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Noonan Syndrome
×
Lamotrigine
×
Clear all
NCT03504501
2023-11-30
SynCoRAS
Technical University of Munich
Phase 2
Terminated
16 enrolled